share_log

Assure | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Assure | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Assure | 425：募资说明/企业合并公告
美股sec公告 ·  05/16 12:16
Moomoo AI 已提取核心信息
On May 14, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, held an adjourned special meeting of stockholders where a significant resolution was passed. The stockholders approved an amendment to the Company's Articles of Incorporation to increase the authorized shares of common stock from 9,000,000 to 250,000,000. This approval was announced in a press release on May 16, 2024. The increase in authorized shares is a strategic move by Assure to facilitate its merger with Danam Health and maintain its NASDAQ listing. The meeting saw a turnout of approximately 60% of the issued and outstanding common stock, with 5,226,969 votes in favor of the amendment. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. Assure...Show More
On May 14, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, held an adjourned special meeting of stockholders where a significant resolution was passed. The stockholders approved an amendment to the Company's Articles of Incorporation to increase the authorized shares of common stock from 9,000,000 to 250,000,000. This approval was announced in a press release on May 16, 2024. The increase in authorized shares is a strategic move by Assure to facilitate its merger with Danam Health and maintain its NASDAQ listing. The meeting saw a turnout of approximately 60% of the issued and outstanding common stock, with 5,226,969 votes in favor of the amendment. The Company plans to promptly file the amendment to effectuate the increase in authorized common stock. Assure's CEO, John Farlinger, expressed gratitude to the stockholders for their support, which enables the management to execute their strategy. The Company has also filed relevant materials with the SEC, including a registration statement on Form S-4 containing a prospectus and a proxy statement, in connection with the proposed transaction with Danam Health.
2024年5月14日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp. 举行了休会特别股东会议，会上通过了一项重要决议。股东批准了公司章程的修正案，将普通股的法定股数从9,000,000股增加到2.5亿股。这项批准是在2024年5月16日的新闻稿中宣布的。增加授权股份是Assure的一项战略举措，旨在促进其与达南健康的合并并维持其在纳斯达克的上市。会议上，约有60％的已发行和流通普通股进行了投票，5,226,969票赞成该修正案。该公司计划立即提交修正案，以实现授权普通股的增加。Assure的首席执行官约翰·法林格对股东的支持表示感谢，这使管理层能够执行他们的战略。该公司还向美国证券交易委员会提交了相关材料，包括一份包含招股说明书和委托书的S-4表格注册声明，与达南健康的拟议交易有关。
2024年5月14日，术中神经监测和远程神经病学服务提供商Assure Holdings Corp. 举行了休会特别股东会议，会上通过了一项重要决议。股东批准了公司章程的修正案，将普通股的法定股数从9,000,000股增加到2.5亿股。这项批准是在2024年5月16日的新闻稿中宣布的。增加授权股份是Assure的一项战略举措，旨在促进其与达南健康的合并并维持其在纳斯达克的上市。会议上，约有60％的已发行和流通普通股进行了投票，5,226,969票赞成该修正案。该公司计划立即提交修正案，以实现授权普通股的增加。Assure的首席执行官约翰·法林格对股东的支持表示感谢，这使管理层能够执行他们的战略。该公司还向美国证券交易委员会提交了相关材料，包括一份包含招股说明书和委托书的S-4表格注册声明，与达南健康的拟议交易有关。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息